» Articles » PMID: 21885577

Substance Use Disorder Among People with First-episode Psychosis: a Systematic Review of Course and Treatment

Overview
Journal Psychiatr Serv
Specialty Psychiatry
Date 2011 Sep 3
PMID 21885577
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: People experiencing a first episode of psychosis frequently have co-occurring substance use disorders, usually involving alcohol and cannabis, which put them at risk for prolonged psychosis, psychotic relapse, and other adverse outcomes. Yet few studies of first-episode psychosis have addressed the course of substance use disorders and the response to specialized substance abuse treatments.

Methods: The authors searched MEDLINE, PsycINFO, and other medical databases for English-language articles published between 1990 and 2009. Included studies addressed two research questions. First, do some clients become abstinent after a first episode of psychosis without specialized substance abuse treatments? Second, for clients who continue to use substances after a first episode of psychosis, does the addition of specialized substance abuse treatment enhance outcomes?

Results: Nine studies without specialized substance abuse treatment and five with specialized substance abuse treatment assessed the course of substance use (primarily cannabis and alcohol) after a first episode of psychosis. Many clients (approximately half) became abstinent or significantly reduced their alcohol and drug use after a first episode of psychosis. The few available studies of specialized substance abuse treatments did not find better rates of abstinence or reduction.

Conclusions: Experience, education, treatment, or other factors led many clients to curtail their substance use disorders after a first episode of psychosis. Specialized interventions for others need to be developed and tested.

Citing Articles

Tobacco, Alcohol, and Drug Use Among Young Adults with Serious Mental Illness.

Ferron J, Brunette M, Aschbrenner K, ElSayed M, Pratt S Community Ment Health J. 2024; 60(5):945-954.

PMID: 38427276 DOI: 10.1007/s10597-024-01246-x.


Remission with or without comorbid substance use disorders in early psychosis: long-term outcome in integrated care (ACCESS III study).

Ruhl F, Lambert M, Rohenkohl A, Kraft V, Daubmann A, Schneider B Front Psychol. 2024; 14:1237718.

PMID: 38187418 PMC: 10768197. DOI: 10.3389/fpsyg.2023.1237718.


Family members' experiences of caring for a relative with substance-induced psychosis disorder.

Selotole S, Temane A, Poggenpoel M Curationis. 2022; 45(1):e1-e9.

PMID: 36453821 PMC: 9724099. DOI: 10.4102/curationis.v45i1.2348.


"It's my frenemy": A qualitative exploration of knowledge and perceptions of fentanyl use during the COVID-19 pandemic in people who use drugs at a syringe services program in Philadelphia, PA.

Bauerle Bass S, Kelly P, Pandit-Kerr S, Pilla J, Morris K, Larsen E Front Public Health. 2022; 10:882421.

PMID: 35937263 PMC: 9353520. DOI: 10.3389/fpubh.2022.882421.


The association of cognitive impairment with quality of life and functional impairment in Ugandan first-episode psychosis patients: a cross sectional study.

Mwesiga E, Ssemata A, Gumikiriza J, Nanteza A, Nakitende A, Nakku J Health Qual Life Outcomes. 2022; 20(1):113.

PMID: 35870969 PMC: 9308281. DOI: 10.1186/s12955-022-02020-x.


References
1.
Saunders J, Aasland O, Babor T, De la Fuente J, Grant M . Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction. 1993; 88(6):791-804. DOI: 10.1111/j.1360-0443.1993.tb02093.x. View

2.
Kavanagh D, Waghorn G, Jenner L, Chant D, Carr V, Evans M . Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample. Schizophr Res. 2004; 66(2-3):115-24. DOI: 10.1016/s0920-9964(03)00130-0. View

3.
Gumley A, OGrady M, McNay L, Reilly J, Power K, Norrie J . Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy. Psychol Med. 2003; 33(3):419-31. DOI: 10.1017/s0033291703007323. View

4.
Wade D, Harrigan S, Edwards J, Burgess P, Whelan G, McGorry P . Course of substance misuse and daily tobacco use in first-episode psychosis. Schizophr Res. 2005; 81(2-3):145-50. DOI: 10.1016/j.schres.2005.09.010. View

5.
Mauri M, Volonteri L, De Gaspari I, Colasanti A, Brambilla M, Cerruti L . Substance abuse in first-episode schizophrenic patients: a retrospective study. Clin Pract Epidemiol Ment Health. 2006; 2:4. PMC: 1435752. DOI: 10.1186/1745-0179-2-4. View